Histochemistry and Cell Biology

, Volume 145, Issue 3, pp 305–313 | Cite as

Cloning of two LIMCH1 isoforms: characterization of their distribution in rat brain and their agmatinase activity

  • David García
  • Patricio Ordenes
  • José Benítez
  • Arlette González
  • María A. García-Robles
  • Vasthi López
  • Nelson Carvajal
  • Elena Uribe
Original Paper


Agmatine, a precursor for polyamine biosynthesis, is also associated with neurotransmitter, anticonvulsant, antineurotoxic and antidepressant actions in the brain. This molecule results from the decarboxylation of l-arginine by arginine decarboxylase, and it is hydrolyzed to urea and putrescine by agmatinase. Recently, we have described a new protein that also hydrolyzes agmatine, agmatinase-like protein (ALP), which was identified through immunohistochemical analysis in the hypothalamus and hippocampus of rats. However, its sequence differs greatly from all known agmatinases and does not contain the typical Mn2+ ligands associated with the urea hydrolase family of proteins. ALP has a LIM-like domain close to its carboxyl terminus, and the removal of which results in a truncated variant with a tenfold increased k cat value and a threefold decreased K m value for agmatine. Analysis of the gene database revealed several transcripts, denominated LIMCH1 isoforms, with extreme 3′ sequences identical to ALP. Limch1 gene products have been described as members of a multi-domain family of proteins with the biggest isoform containing a calponin homology (CH) domain at its N-terminus. Here, we cloned two LIMCH1 transcripts, one of 3177 bp and the other of 2709 bp (ALP contains 1569 bp) and analyzed LIMCH1 expression and distribution in rat brain using RT-PCR, Western blot and immunohistochemical analyses. LIMCH1 was detected mainly in the hypothalamic and hippocampal regions, which is similar to the distribution of ALP and agmatine in brain. In addition, we cloned and expressed both isoforms in E. coli and confirmed that they were catalytically active on agmatine with kinetic parameters similar to ALP. LIM domain-truncated variants of both isoforms moderately increased the k cat and catalytic efficiency. Thus, we propose that LIMCH1 is useful to regulate the intracellular concentrations of the neurotransmitter/neuromodulator, agmatine.


Agmatine LIMCH1 Hypothalamus LIM domain 



This research was supported by Grant Fondecyt 1120663 and Grant VRID-Enlace 251.037.019-1.0.


  1. Agostinelli E, Marques MP, Calheiros R, Gil FP, Tempera G, Viceconte N, Battaglia V, Grancara S, Toninello A (2010) Polyamines: fundamental characters in chemistry and biology. Amino Acids 38:393–403CrossRefPubMedGoogle Scholar
  2. Castro V, Fuentealba P, Henríquez A, Vallejos A, Benítez J, Lobos M, Díaz B, Carvajal N, Uribe E (2011) Evidence for an inhibitory LIM domain in a rat brain agmatinase-like protein. Arch Biochem Biophys 512:107–110CrossRefPubMedGoogle Scholar
  3. Chan SL (1998) Clonidine-displacing substance and its putative role in control of insulin secretion: a mini review. Gen Pharmacol 31:525–529CrossRefPubMedGoogle Scholar
  4. Chang CH, Wu HT, Cheng KC, Lin HJ, Cheng JT (2010) Increase of beta-endorphin secretion by agmatine is induced by activation of imidazoline I (2A) receptors in adrenal gland of rats. Neurosci Lett 468:297–299CrossRefPubMedGoogle Scholar
  5. Cofre J, Montes P, Vallejos A, Benítez J, García D, Martínez-Oyanedel J, Carvajal N, Uribe E (2014) Further insight into the inhibitory action of a LIM/double zinc-finger motif of an agmatinase-like protein. J Inorg Biochem 132:92–95CrossRefPubMedGoogle Scholar
  6. Feuerstein R, Wang X, Song D, Cooke NE, Liebhaber SA (1994) TheLIM/double zinc-finger motif functions as a protein dimerization domain. Proc Natl Acad Sci 91:10655–10659PubMedCentralCrossRefPubMedGoogle Scholar
  7. Friedberg F (2009) Alternative splicing for members of human mosaic domain superfamilies. I. The CH and LIM domains containing group of proteins. Mol Biol Rep 36:1059–1081CrossRefPubMedGoogle Scholar
  8. Halaris A, Piletz J (2007) Agmatine: metabolic pathway and spectrum of activity in brain. CNS Drugs 21:885–900CrossRefPubMedGoogle Scholar
  9. Hornbeck P, Chabra I, Kornhauser J, Skrzypek E, Zhang B (2004) Phosphosite: a bioinformatics resource dedicated to physiological protein phosphorylation. Proteomics 4:1551–1561CrossRefPubMedGoogle Scholar
  10. Iyer RK, Kim HK, Tsoa RW, Grody WW, Cederbaum SD (2002) Cloning and characterization of human agmatinase. Mol Genet Metab 75:209–218CrossRefPubMedGoogle Scholar
  11. Iyo A, Zhu M, Ordway G, Regunathan S (2006) Expression of arginine decarboxylase in brain regions and neuronal cells. J Neurochem 96:1042–1050PubMedCentralCrossRefPubMedGoogle Scholar
  12. Kadrmas J, Beckerle M (2004) The LIM domain: from the cytoskeleton to the nucleus. Nat Rev Mol Cell Biol 5:920–931CrossRefPubMedGoogle Scholar
  13. Lee WT, Hong S, Yoon SH, Kim JH, Park KA, Seong GJ, Lee JE (2009) Neuroprotective effects of agmatine on oxygen-glucose deprived primary-cultured astrocytes and nuclear translocation of nuclear factor-kappa B. Brain Res 1281:64–70CrossRefPubMedGoogle Scholar
  14. Lee JP, Chen W, Wu HT, Lin KC, Cheng JT (2011) Metformin can activate imidazoline I-2 receptors to lower plasma glucose in type 1-like diabetic rats. Horm Metab Res 43:26–30CrossRefPubMedGoogle Scholar
  15. Li J, Ning Y, Hedley W, Saunders B, Chen Y, Tindill N, Hannay T, Subramaniam S (2002) The molecule pages database. Nature 420:716–717CrossRefPubMedGoogle Scholar
  16. Li F, Wu N, Su R, Chen Y, Lu X, Liu Y (2011) Imidazoline receptor antisera-selected/Nischarin regulates the effect of agmatine on the development of morphine dependence. J Addict Biol 17:392–408CrossRefGoogle Scholar
  17. Maturana AD, Nakakawa N, Yoshimoto N, Tatematsu K, Hoshijima K, Kuroda S (2011) LIM domains regulate protein kinase C activity: a novel molecular function. Cell Signal 23:928–934CrossRefPubMedGoogle Scholar
  18. Mella C, Martínez F, García M, Nualart F, Castro V, Bustos P, Carvajal N, Uribe E (2010) Expression and localization of agmatinase-like protein in rat brain. Histochem Cell Biol 134:137–144CrossRefPubMedGoogle Scholar
  19. Mistry SK, Burwell TJ, Chambers RM, Rudolph-Owen L, Spaltmann F, Cook WJ, Morris SM Jr (2002) Cloning of human agmatinase. An alternate path for polyamine synthesis induced in liver by hepatitis B virus. Am J Physiol Gastrointest Liver Physiol 282:375–381CrossRefGoogle Scholar
  20. Mun CH, Lee WT, Park KA, Lee JE (2010) Regulation of endothelial nitric oxide synthase by agmatine after transient global cerebral ischemia in rat brain. Anat Cell Biol 43:230–240PubMedCentralCrossRefPubMedGoogle Scholar
  21. Penner SB, Smyth DD (1996) Natriuresis following central and peripheral administration of agmatine in the rat. Pharmacology 53:160–169CrossRefPubMedGoogle Scholar
  22. Piletz JE, Aricioglu F, Cheng JT, Fairbanks CA, Gilad VH, Haenisch B, Halaris A, Hong S, Lee JE, Li J, Liu P, Molderings GJ, Rodrigues AL, Satriano J, Seong GJ, Wilcox G, Wu N, Gilad GM (2013) Agmatine: clinical applications after 100 years in translation. Drug Discov Today 18:880–893CrossRefPubMedGoogle Scholar
  23. Qiu WW, Zheng RY (2006) Neuroprotective effects of receptor imidazoline 2 and its endogenous ligand agmatine. Neurosci Bull 22:187–191PubMedGoogle Scholar
  24. Quiñones M, Cofre J, Benítez J, García D, Romero N, González A, Carvajal N, García M, López V, Schenk G, Uribe E (2015) Insight on the interaction of an agmatinase-like protein with Mn(2+) activator ions. J Inorg Biochem 145:65–69CrossRefPubMedGoogle Scholar
  25. Sastre M, Regunathan S, Galea E, Reis DJ (1996) Agmatinase activity in rat brain: a metabolic pathway for the degradation of agmatine. J Neurochem 67:1761–1765CrossRefPubMedGoogle Scholar
  26. Sastre M, Galea E, Feinstein D, Reis DJ, Regunathan S (1998) Metabolism of agmatine in macrophages: modulation by lipopolysaccharide and inhibitory cytokines. Biochem J 330:1405–1409PubMedCentralCrossRefPubMedGoogle Scholar
  27. Satriano J, Cunard R, Peterson OW, Dousa T, Gabbai FB, Blantz RC (2007) Effects on kidney filtration rate by agmatine requires activation of ryanodine channels for nitric oxide generation. Am J Physiol Renal Physiol 294:795–800CrossRefGoogle Scholar
  28. Sjöblom B, Ylänne J, Djinoviæ-Carugo K (2008) Novel structural insights into F-actin-binding and novel functions of calponin homology domains. Curr Opin Struct Biol 18:702–708CrossRefPubMedGoogle Scholar
  29. Su CH, Liu IM, Chung HH, Cheng JT (2009) Activation of I2-imidazoline receptors by agmatine improved insulin sensitivity through two mechanisms in type-2 diabetic rats. Neurosci Lett 457:125–128CrossRefPubMedGoogle Scholar
  30. Tahsili P, Yahyavi N, Khoshnoodi M (2006) Agmatine potentiates morphine-induced conditioned place preference in mice: modulation by alpha(2)-adrenoceptors. Neuropsypharmocology 31:1722–1732CrossRefGoogle Scholar
  31. Uribe E, Salas M, Enriquez S, Orellana MS, Carvajal N (2007) Cloning and functional expression of a rodent brain cDNA encoding a novel protein with agmatinase activity, but not belonging to the arginase family. Arch Biochem Biophys 461:146–150CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • David García
    • 1
  • Patricio Ordenes
    • 2
  • José Benítez
    • 3
  • Arlette González
    • 3
  • María A. García-Robles
    • 2
  • Vasthi López
    • 4
  • Nelson Carvajal
    • 3
  • Elena Uribe
    • 3
  1. 1.Departamento de Ciencias Biológicas y Químicas, Facultad de CienciasUniversidad San SebastiánConcepciónChile
  2. 2.Departamento de Biología Celular, Facultad de Ciencias BiológicasUniversidad de ConcepciónConcepciónChile
  3. 3.Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias BiológicasUniversidad de ConcepciónConcepciónChile
  4. 4.Departamento de Ciencias BiomédicasUniversidad Católica del NorteCoquimboChile

Personalised recommendations